Top 3 Factors Shaping the Bioimpedance Devices Market
Digitization in the Healthcare Sector
Companies are focused on the development of products that offer economic as well as clinical relevance to the overall business. This can be attributed to factors such as the expansion of the healthcare sector in developing countries and investments in healthcare information technology by governments as well as public sector organisations.
Moreover, increasing healthcare spending, coupled with efforts by manufacturers to offer innovative bioimpedance devices to cater to the increasing demand for sophisticated solutions in developing countries, is also expected to drive the growth of the bioimpedance devices market in the near future.
Increasing Prevalence of Chronic Kidney Disease
Chronic Kidney Disease (CKD) is a condition that can be characterised by the gradual loss of kidney function over time. According to the National Kidney Foundation, Inc., 30 million American adults suffer from CKD and millions of others are at a high risk of developing CKD, and Glomerular Filtration Rate (GFR) is the best overall index of kidney function.
Bioelectrical impedance or bioimpedance can be used to predict muscle mass and improve the estimation of glomerular filtration rate in non-diabetic patients suffering from chronic kidney disease. Bioelectrical Impedance Analysis (BIA) can be used to estimate the Appendicular Lean Mass (ALM).
Growing Obese Population
Obesity is one of the most important public health concerns worldwide as it increases the risk of developing disorders such as strokes, high blood pressure, heart diseases, etc., and bioimpedance devices are mostly used in the treatment of the same. Since 1975, the obese population has grown extensively worldwide.
According to a World Health Organization (WHO) estimate, in 2016, more than 1.9 billion adults aged 18 years and above were overweight. Of these, over 650 million adults were obese. Bioimpedance devices can be used for the diagnosis of obesity since they can measure the fat content in patients, among other parameters. Thus, growth in the obese population is expected to fuel the growth of the bioimpedance devices market.
Market Research Methodology - Perfected through Years of Diligence
A key factor for our unrivaled market research accuracy is our expert- and data-driven research methodologies. We combine an eclectic mix of experience, analytics, machine learning, and data science to develop research methodologies that result in a multi-dimensional, yet realistic analysis of a market.
Bioimpedance Devices Market Structure Analysis
- The top four players of the bioimpedance devices market contribute to over 50% of the market value.
- Some of the key players in the bioimpedance devices market include General Electric Company, Omron Healthcare Inc., ImpediMed Ltd., Seca, RJL Systems Inc., Soehnle, and Bodystat.
- Most players are focused on developing and enhancing their product offerings.
- Product launches are among the key strategic focuses of leading players in the market.
Bioimpedance Devices Paving their Way through Healthcare and Medical Research
Bioimpedance devices are widely used in healthcare and medical research. Although this technology is mostly popular as body fat measuring scales, they are also widely used in critical medical applications such as weight loss and obesity management the pulmonary function, renal function, different treatment procedures, and in vivo diagnostics.
Market Set to Grow by 2.2X between 2018 and 2028
Increase in obese population, growth in the prevalence of chronic kidney disease, as well as increasing disposable income is expected to result in the robust growth of the bioimpedance devices market throughout the forecast period.
Emerging Countries – Asia Pacific to display significant growth opportunities
North America and Europe are expected to contribute a prominent share of the bioimpedance devices market in 2017. Regions such as APEJ are expected to witness significant growth due to the high adoption of bioimpedance devices in India, China, and other ASEAN countries.
The rising number of Chinese players in the market is expected to boost the growth of the bioimpedance devices market in China. Similarly, other local manufacturers in the Asia Pacific region are expected to support the growth of the market
The Broader Perspective
Online marketing has led to a rapid increase in the sale of portable and handheld bioimpedance devices in the recent years. Vendors operating in the market are focusing on online marketing and promotional strategies to ensure better access to their devices and increase sales.
Devices offered online also help vendors minimise distribution and operational costs. Online marketing websites offer a wide selection of branded bioimpedance systems at low costs.
How Growth will Unfold
The popularity of portable bioimpedance devices is increasing due to their various advantages. Portable bioimpedance devices are non-invasive, low-cost, safe, portable, and easy to use. These devices are light in weight and can be used in households for the monitoring of the health of the entire family.
All these factors are expected to cumulatively drive the demand for portable bioimpedance devices during the forecast period.
On the basis of product type
- Single-frequency Bioimpedance Devices
- Multiple-frequency Bioimpedance Devices
On the basis of Modality
- Wired Bioimpedance Devices
- Wireless Bioimpedance Devices
On the basis of end users
- Specialty Clinics
- Rehabilitation Centers
On the basis of Region-wise
- North America
- Latin America
- Eastern Europe
- Western Europe
- Asia-Pacific excluding Japan
- Middle East & Africa